IVD_Manufacturing

Description: MoAb to DHEAS Monoclonal Antibody to DehydroepiandrosteroneSulfate
Catalog #: 11F0301
Format: Liquid Frozen
Host Animal: Mouse
Isotype: Monoclonal IgG К
Source: Mouse Ascites

Dehydroepiandrosterone is the most abundant adrenal androgen in humans and exists predominately in a sulfated form (DHEAS).
DHEA sulfotransferase, known as SULT2A1, converts the androgen precursor DHEA to its inactive sulfate ester, DHEAS.
The unconjugated molecules can be converted directly to androgens. Dehydroepiandrosterone is converted to DHEAS in the adrenal glands and liver. DHEA in adults is present at plasma concentrations 100 to 500 times higher than those of testosterone.
DHEA can be metabolized to androgens and/or estrogens in the prostate. Hepatic metabolites include 16α-hydroxy-DHEA, 7α-hydroxy-DHEA, and 7-oxo-DHEA . 7beta-OH-DHEA is a metabolite.
The major metabolite produced in humans is a mono-hydroxylated DHEA species . Synthesis of a 7α-hydroxy-DHEA and 5-androstene-3β, 17β-diol occurs in the frontal cortex, hippocampus, amygdala, cerebellum and striatum.

Material Safety Data Sheet (MSDS): 

For ordering please contact: order@future-diagnostics.nl

 

Future Diagnostics has developed a new and innovative release reagent that can be used in immuno assays for 25-OH-Vitamin-D.
Please refer to the attached patent.

 

 

For ordering please contact: order@future-diagnostics.nl

The Free 25OH Vitamin D ELISA (developed by Future Diagnostics with DIAsource patented monoclonal Antibodies), is a unique, practical and automatable immunoassay for the measurement of free 25OH Vitamin D in serum. Future Diagnostics holds also a patent on the measurement of Free 25-OH-Vitamin-D.

PM0T9027_resized

For a description of the assay refer to the following document:

 

Material Safety Data Sheet (MSDS)

Future Diagnostics has granted DIAsource ImmunoAssays for the commercialization of this assay.

You can find ordering details on their product page at: www.diasource-diagnostics.com